Tag Archives: Bacillus Calmette–Guérin

New TB Vaccine successfully completes a small trial

A new vaccine against Tuberculosis has successfully completed an early trial. Developed by Glaxo Smithkline amd Aeras, the M72 vaccine reduced TB rates by more than half. The current vaccine against TB is Bacillus Calmette–Guérin (BCG). Its effectiveness in children … Continue reading

Posted in Anti-antivaccination, Background Data | Tagged , , , , ,